PROQR THERAPEUTICS EO-04 (0PQ) — Cash Flow-to-Debt Ratio
PROQR THERAPEUTICS EO-04 (0PQ) has a Cash Flow-to-Debt Ratio of -0.21x as of December 2025, meaning its operating cash flow of €-13.36 Million could theoretically repay 0% of its total liabilities (€63.38 Million) in one year. See 0PQ free cash flow to operating cash ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
PROQR THERAPEUTICS EO-04 Cash Flow-to-Debt Ratio (2021–2025)
Historical debt coverage capacity for PROQR THERAPEUTICS EO-04 across 5 annual periods. Also explore 0PQ net asset momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for PROQR THERAPEUTICS EO-04 (2021–2025)
Year-by-year debt coverage analysis for PROQR THERAPEUTICS EO-04. For market capitalisation and broader financial context, see 0PQ stock market capitalisation.
| Year | CF-to-Debt Ratio | Operating CF (EUR) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -0.83x | €-52.79 Million | €63.38 Million | ▼ -81.7% |
| 2024 | -0.46x | €-36.39 Million | €79.40 Million | ▼ -305.3% |
| 2023 | 0.22x | €21.55 Million | €96.49 Million | ▲ +134.1% |
| 2022 | -0.65x | €-68.51 Million | €104.64 Million | ▼ -142.5% |
| 2021 | -0.27x | €-26.01 Million | €96.35 Million | — |